These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28537720)

  • 1. Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances.
    Reis J; Gaspar A; Milhazes N; Borges F
    J Med Chem; 2017 Oct; 60(19):7941-7957. PubMed ID: 28537720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromones as a privileged scaffold in drug discovery: a review.
    Keri RS; Budagumpi S; Pai RK; Balakrishna RG
    Eur J Med Chem; 2014 May; 78():340-74. PubMed ID: 24691058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges with chromone as a privileged scaffold in drug discovery.
    Silva CFM; Batista VF; Pinto DCGA; Silva AMS
    Expert Opin Drug Discov; 2018 Sep; 13(9):795-798. PubMed ID: 29985064
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromones: Privileged scaffold in anticancer drug discovery.
    Patil VM; Masand N; Verma S; Masand V
    Chem Biol Drug Des; 2021 Nov; 98(5):943-953. PubMed ID: 34519163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromone Containing Hybrid Analogs: Synthesis and Applications in Medicinal Chemistry.
    Auti PS; Jagetiya S; Paul AT
    Chem Biodivers; 2023 Aug; 20(8):e202300587. PubMed ID: 37332056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel A3 adenosine receptor ligands based on chromone scaffold.
    Gaspar A; Reis J; Kachler S; Paoletta S; Uriarte E; Klotz KN; Moro S; Borges F
    Biochem Pharmacol; 2012 Jul; 84(1):21-9. PubMed ID: 22433284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromone, A Privileged Scaffold in Drug Discovery: Developments in the Synthesis and Bioactivity.
    Benny AT; Arikkatt SD; Vazhappilly CG; Kannadasan S; Thomas R; Leelabaiamma MSN; Radhakrishnan EK; Shanmugam P
    Mini Rev Med Chem; 2022; 22(7):1030-1063. PubMed ID: 34819000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromones: A Promising Ring System for New Anti-inflammatory Drugs.
    Silva CF; Pinto DC; Silva AM
    ChemMedChem; 2016 Oct; 11(20):2252-2260. PubMed ID: 27630077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation.
    Liu Z; Chen H; Wang P; Li Y; Wold EA; Leonard PG; Joseph S; Brasier AR; Tian B; Zhou J
    J Med Chem; 2020 May; 63(10):5242-5256. PubMed ID: 32255647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of chromone-like compounds as potential antileishmanial agents, through the 21
    Silva CFM; Pinto DCGA; Fernandes PA; Silva AMS
    Expert Opin Drug Discov; 2020 Dec; 15(12):1425-1439. PubMed ID: 32783762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromone: a valid scaffold in medicinal chemistry.
    Gaspar A; Matos MJ; Garrido J; Uriarte E; Borges F
    Chem Rev; 2014 May; 114(9):4960-92. PubMed ID: 24555663
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and NMR studies of novel chromone-2-carboxamide derivatives.
    Gaspar A; Cagide F; Quezada E; Reis J; Uriarte E; Borges F
    Magn Reson Chem; 2013 Apr; 51(4):251-4. PubMed ID: 23408556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological activities of non-flavonoid chromones: a patent review (from 2005 to 2015).
    Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Borges F
    Expert Opin Ther Pat; 2015; 25(11):1285-304. PubMed ID: 26291463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis.
    Gobbi S; Hu Q; Zimmer C; Engel M; Belluti F; Rampa A; Hartmann RW; Bisi A
    J Med Chem; 2016 Mar; 59(6):2468-77. PubMed ID: 26938274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
    Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F
    Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
    Legoabe LJ; Petzer A; Petzer JP
    Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.
    Madhav H; Jameel E; Rehan M; Hoda N
    RSC Med Chem; 2022 Mar; 13(3):258-279. PubMed ID: 35434628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In search for new chemical entities as adenosine receptor ligands: development of agents based on benzo-γ-pyrone skeleton.
    Gaspar A; Reis J; Matos MJ; Uriarte E; Borges F
    Eur J Med Chem; 2012 Aug; 54():914-8. PubMed ID: 22703703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of chroman-4-one derivatives: synthetic approaches and bioactivities.
    Emami S; Ghanbarimasir Z
    Eur J Med Chem; 2015 Mar; 93():539-63. PubMed ID: 25743215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives.
    Kim MK; Yoon H; Barnard DL; Chong Y
    Chem Pharm Bull (Tokyo); 2013; 61(4):486-8. PubMed ID: 23546009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.